We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
TIDMGSK
RNS Number : 0523S
GlaxoSmithKline PLC
01 November 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ======================================================================= a) Name Ms E Walmsley === ======================== ============================================= b) Position/status Chief Executive Officer === ======================== ============================================= c) Initial notification/ Initial notification amendment === ======================== ============================================= 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ======================================================================= a) Name GlaxoSmithKline plc === ======================== ============================================= b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================= 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ======================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================= b) Nature of the The exercise of options over 137,040 Ordinary transaction Shares, granted on 22 July 2010 under the GlaxoSmithKline 2009 Share Option Plan. === ======================== ============================================= c) Price(s) and Price(s) Volume(s) volume(s) GBP12.035 137,040 ---------- === ======================== ============================================= d) Aggregated information N/A (single transaction) Aggregated volume Price === ======================== ============================================= e) Date of the transaction 2019-10-31 === ======================== ============================================= f) Place of the N/A transaction === ======================== ============================================= 1. Details of PDMR/person closely associated with them ('PCA') ====================================================================== a) Name Ms E Walmsley === ======================== ============================================ b) Position/status Chief Executive Officer === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the The sale of 112,945 Ordinary Shares to transaction cover the tax and cost of exercise of the options granted on 22 July 2010 under the GlaxoSmithKline 2009 Share Option Plan. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) GBP17.7588 112,945 ---------- === ======================== ============================================ d) Aggregated information N/A (single transaction) Aggregated volume Price === ======================== ============================================ e) Date of the transaction 2019-10-31 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') ========================================================================================== a) Name Ms E Walmsley ==== ====================================== ================================================== b) Position/status Chief Executive Officer ==== ====================================== ================================================== c) Initial notification/ Initial Notification amendment ==== ====================================== ================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ================================================== b) Nature of the Transfer of 24,095 Ordinary Shares to transaction spouse for nil consideration. ==== ====================================== ================================================== c) Price(s) and volume(s) Price(s) Volume(s) ==== ====================================== ======================= ====================== GBP0.00 24,095 =================================================================== ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================ ============================= e) Date of the transaction 2019-10-31 ==== ====================================== ================================================== f) Place of the transaction N/A ====================================== ================================================== Details of PDMR/person closely associated with them ('PCA') ========================================================================================== a) Name Mr David Owen ==== ====================================== ================================================== b) Position/status PCA of Ms E Walmsley (Chief Executive Officer) ==== ====================================== ================================================== c) Initial notification/ Initial Notification amendment ==== ====================================== ================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ========================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares')
instrument ISIN: GB0009252882 ==== ====================================== ================================================== b) Nature of the Receipt of 24,095 Ordinary Shares from transaction spouse for nil consideration. ==== ====================================== ================================================== c) Price(s) and volume(s) Price(s) Volume(s) ==== ====================================== ======================= ====================== GBP0.00 24,095 =================================================================== ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ================================================================ ============================= e) Date of the transaction 2019-10-31 ==== ====================================== ================================================== f) Place of the transaction N/A ====================================== ==================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHDFLFBKFFFFBE
(END) Dow Jones Newswires
November 01, 2019 13:19 ET (17:19 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions